The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
Still up?
Eyeguy.... no you didn’t so stop making out like you bought that day, I remember it like it was yesterday, the drop to 1p was for like 3mins tops and no one was able to buy, shortly afterwards at 2.5p those that could did in tiny chunks of £100 so stop playing out like you’re in massive profit and your advice is golden. Perhaps one should take a look at your past advice, if I recall correctly CRA went bust following your massive ramp didn’t they? And you hyped EVG at 28p saying 50p+ then it plummeted, I notice you linger on boards that are all about hype then you disappear shortly afterwards, you sir are a con artist in the most conniving form, it’s not shares I should stay away from but people like you.
Yes it had! It went up to 9.35p didn’t it? It was sat at 8.5p for a couple of days before the news release and all the way from 6p
I pointed out it was a clear example of a ‘pump and dump’.... FACT! You got all defensive by making a personal attack on me through looking my post history and commenting. If you care to take a minute and read a post properly without being so defensive then you would have understood my point, as a result, you have diluted the point I was trying to get across, you have wasted a good 15mins of my morning, yours and anyone who has taken the time to read it.
My initial post still stands! This was a clear example of pump and dump, the news had already been factored into the SP before it had been released and that influenced by sellers.
You’ve had your five minutes of fame, now go drop your kids off at the baby sitters and take lunch
Johnny if you are in profit as you claim to be, I suggest you to take profit, that’s about the soundest advice I can give you or anyone else here.
I don’t know why my initial post hit a nerve with you, perhaps my insight on Eyeguy insulted you, perhaps your moniker is a disguise, guess we will never know, but for those who have been caught in ‘P&D’ scenarios my post would be insightful for them, if they haven’t already figured it out.
Your posts trying to discredit me is laughable, yet quite pathetic
Johnny... Mike29 pointed out the potential, I acknowledged, then you claimed I was a ‘know it all’ so I responded to you by stipulating that.
You are clearly hurting by your loss, I get it, we all are
Johnny.... your missing the point..... I do my research but I was pointing out what is going on here which has clearly gone over your head, again You are being defensive.
FYI I fully know the potential of NCCL and a hell of a lot better than you having been in NCCL for over 2 years, and yes you will be chasing, price is 7% down now so go figure.
Johnysingh..... don’t get so defensive, I just wrote a post pointing out the obvious. Clearly you just went through my post history and saw EVG, so let’s talk about EVG, another clear example of a ‘pump and dump’ which I was the victim of, and all thanks to yours truly ‘Eyeguy’ who claimed a 10 bagger for a £5bn company.
I never claimed to be making money in AIM, I have eye watering paper losses thanks to the scenarios I’ve experienced and shared with you, so perhaps be grateful. Yes no one knows where the price will end up, but you are chasing now ain’t you?
You guys are all fikkle if you haven’t figured out AIM yet, this is classic display of ‘pump and dump’, the price rose from 5p to 9p in anticipation of the deal with your usual hype merchants (Eyeguy) on the scene, now it will trace back down to 5p and build again on anticipation of next news before tracing back down again, that’s just how AIM works, take profits where you can and don’t get locked in. It will be hyped by certain individuals to trap PI’s in while they sell and re-buy back in once the dust settles.
Evgen (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that it has received notice to exercise options over 321,600 ordinary shares in the Company. Options over 321,600 shares were exercised pursuant to grants under individual option agreements with an exercise price of 0.875p per share. Accordingly, the Company has issued and allotted 321,600 new ordinary shares of 0.25 pence each ("New Ordinary Shares"). The New Ordinary Shares rank pari passu with the Company's existing issued ordinary shares. Application has been made to admit the New Ordinary Shares to trading on AIM and dealings in these shares are expected to commence at 8.00 a.m. on 24 May 2019. There are no shares held in treasury, therefore following the admission of the New Ordinary Shares the total number of voting rights in the Company will be 132,646,263. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest under the Disclosure and Transparency Rules.
Someone’s just invested another £1.2m here, two tranches of 3m, so within the last two trading weeks someone’s acquired a total of £2.2m (circa 12% the company) and all within 4 trades! A TR1 notification has to be due soon.
I am the last man standing here? Wtf has happened here today?.... leak? and where is our resident ramper?
They most likely will be looking at grants, the last few were, so this will likely continue but yet to be confirmed, I think grant funding is the way forward as it’s taken research to current levels and in-situ. I would never say never about placings, after all.... this is AIM
Put it in your bottom draw, should it come to fruition then consider it a blessing, but the lesson to take away from all this is that director activities on AIM listed companies are largely corrupt if not biased for their own financial gain, and all this openly displayed on an unregulated platform. Take your monies out of AIM and you’re already a winner!
finnCap issued to investors and clients in a recent report that it has initiated coverage on Evgen Pharma Plc (LON:EVG) stock, with a “Corporate” rating and a GBX 45.00 TP. https://www.sharesmagazine.co.uk/news/market/6371283/Broker-Forecast-finnCap-issues-a-broker-note-on-Evgen-Pharma-Plc
Podcast Sep 18 on their website with VoxMarket discusses in briefl the prospects of commercialisation of both drugs after phase 2. There may be some more substantial evidence out there but so far all I’ve seen/heard
Locked into another AIM share for a couple of months/years, story of my life!
A lot of buys disguised as sells, my 10k seen as a sell, MMS will fall short of shares soon and this should pick up
For those that missed it you can find it here once it’s been uploaded.... http://evgen.com